Spacer
Spacer
SEARCH
Spacer
Spacer
Quotes News NAV
Spacer
Spacer
Spacer
Spacer
Spacer
Financial Ratios Markets  >  Corporate Information  >   Financial Ratios
Spacer
Krebs Biochemicals & Industries Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
524518 INE268B01013 -75.4893276 KREBSBIO 0 142.82 0 0 10
Your Result on : Markets | Equity | Corporate Information | Financial Ratios
ParticularsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.002.830.782.230.00
Long Term Debt-Equity Ratio0.002.340.541.740.00
Current Ratio0.170.300.410.450.44
Fixed Assets0.140.160.180.220.21
Inventory5.474.642.782.833.40
Debtors44.4241.5073.94101.19214.80
Interest Cover Ratio-3.55-3.21-7.31-7.26-3.52
PBIDTM (%)-33.06-16.40-29.08-55.01-31.56
PBITM (%)-48.51-29.83-41.67-65.56-41.10
PBDTM (%)-46.71-25.70-34.78-64.04-43.26
CPM (%)-46.76-25.70-34.78-64.04-43.28
APATM (%)-62.20-39.13-47.36-74.59-52.81
ROCE (%)0.000.000.000.000.00
RONW (%)0.000.000.000.000.00
Spacer